Before and After ED Injections: Two Procedures, One Decision Guide

A man typing “before and after ED injections” into a search bar is often researching two entirely different procedures without realizing it. One category restores the ability to achieve a firm erection. The other increases girth and improves appearance. They share the word “injection,” but they share almost nothing else.

That confusion matters. Erectile dysfunction now affects an estimated 322 million men worldwide as of 2025, up from 152 million in 1995, according to Johns Hopkins Medicine. Yet not every man searching this phrase has a clinical ED diagnosis. Many are visually driven, looking for real-world evidence of what changes, and quietly evaluating whether an injectable solution could address a concern they have carried in silence for years.

This guide provides a clinical, side-by-side comparison framework. It separates intracavernosal vasoactive injections (functional ED treatment) from subcutaneous hyaluronic acid filler injections (aesthetic girth enhancement) so a reader can identify which injectable category actually matches his goal. It is written for the high-achieving professional in his 30s or 40s who is open to injectable solutions but wants clarity before committing to a consultation. The tone respects intelligence, evidence, and privacy in equal measure.

The Critical Distinction Most Articles Miss: Two Types of “ED Injections”

The phrase “ED injections” is used loosely online to describe two clinical categories with different mechanisms, different goals, and completely different outcome profiles.

Category 1: Intracavernosal vasoactive injections. These are on-demand functional treatments (alprostadil, Trimix, botulinum toxin A, PRP) injected directly into the erectile tissue to force vasodilation and produce an erection.

Category 2: Subcutaneous aesthetic filler injections. These are girth enhancement procedures (hyaluronic acid filler, polylactic acid) placed beneath the penile skin to increase circumference and improve appearance, with no mechanism for treating erectile dysfunction.

These categories are not interchangeable. ED injections do not increase size. Filler injections do not treat erectile dysfunction. Think of it as a treatment ladder: on-demand ED injections, then regenerative injections (PRP and BoNT-A), then aesthetic girth enhancement (HA filler). Some men have both functional and aesthetic concerns, and a combination approach may be appropriate, a point worth revisiting during a proper consultation.

Category 1: Intracavernosal Vasoactive Injections for Erectile Dysfunction

Intracavernosal injection (ICI) therapy is a second-line ED treatment, typically used when oral PDE5 inhibitors like Viagra or Cialis are ineffective or contraindicated. The three primary agents are alprostadil (the only FDA-approved ICI agent), Trimix (alprostadil combined with papaverine and phentolamine), and emerging options like botulinum toxin A and PRP.

The mechanism is direct: vasoactive agents relax smooth muscle and dilate penile arteries, producing an erection within 5 to 15 minutes regardless of sexual stimulation. A January 2026 NIH literature review confirmed ICI therapy as a cornerstone of penile rehabilitation following radical prostatectomy and for men unresponsive to oral medications.

The “before and after” here is measured in functional terms: rigidity scores, IIEF scores, and erection hardness. Not size. Not appearance.

Alprostadil and Trimix: Before and After Outcome Data

The measurable outcomes are strong. A World Journal of Urology systematic review found ICI therapy demonstrates clinical efficacy in 54 to 100 percent of patients, with early discontinuation rates at or below 38 percent and adverse events at or below 26 percent.

Long-term data is compelling. In a study of 105 patients with a mean ICI use of 8.4 years, penile rigidity improved from 41.1 percent to 89.6 percent, and IIEF scores rose from 33.0 to 60.0, per the International Journal of Impotence Research.

Trimix specifically carries an approximate 80 to 90 percent success rate in men who did not respond to oral pills, with erections occurring within 5 to 15 minutes and lasting up to one hour. One important caveat: 20 to 40 percent of patients report injection-site pain with alprostadil, which is why Trimix (using a lower alprostadil dose combined with two other agents) is often preferred without compromising efficacy, according to NIH StatPearls.

The key limitation is unambiguous: these injections produce a temporary, on-demand erection. They do not change penile size, girth, or appearance in any measurable way.

Botulinum Toxin A (BoNT-A / BoCox): The Emerging Regenerative Option

BoNT-A intracavernosal injection differs from on-demand alprostadil. It works by modulating smooth muscle tone and neurotransmitter release rather than forcing immediate vasodilation. A comprehensive systematic review of 51 studies published in November 2025 found response rates of 40 to 77.5 percent, with effects persisting up to six months from a single injection.

A 2025 Oxford meta-analysis in Sexual Medicine confirmed statistically significant improvements in Erection Hardness Score and Peak Systolic Velocity, positioning BoNT-A as a viable first- or second-line option. Notably, one NIH study found response rates increased with successive treatments: 67.5 percent after the first injection, 87.5 percent after the second, and 94.7 percent after the third, suggesting cumulative benefit.

The practical advantage is reduced treatment burden: one injection every six months versus an injection before every sexual encounter. BoNT-A’s smooth muscle relaxation can also improve flaccid penile appearance and perceived length, a nuanced effect that partially bridges the functional and aesthetic narratives. Mild transient penile pain is the most common adverse event.

PRP (Platelet-Rich Plasma) Injections: Regenerative ED Treatment

PRP is a regenerative rather than on-demand approach, using the patient’s own growth factors to promote vascular repair in erectile tissue. A BMC Urology study published in October 2024 showed EHS improving from 2.15 to 3.15 and IIEF-5 scores from 10.92 to 17.23 post-treatment, with no hemorrhagic adverse events and statistically significant improvement in penile Doppler resistance index.

PRP is often discussed alongside aesthetic procedures (the “P-Shot”), but its primary evidence base is functional ED improvement, not size. Results are more modest and variable than Trimix or BoNT-A, making PRP best suited for men with mild-to-moderate ED seeking a natural, low-risk regenerative option. It does not increase girth.

The ICI Therapy Risk Profile: What to Know Before Starting

The most serious ICI risk is priapism. ICI-related priapism accounts for 54.8 percent of all priapism cases in one April 2025 ScienceDirect study, with 57 percent of affected patients discontinuing therapy afterward. Proper dosing, patient education, and clinical supervision dramatically reduce this risk. This is not a reason to avoid ICI therapy; it is a reason to pursue it through qualified providers.

Other adverse events include injection-site pain, bruising, and fibrosis with long-term use, all manageable with proper technique. Recreational use outside medical supervision is associated with significantly worse outcomes, including de novo ED. ICI therapy remains clinically validated and widely used, with a well-characterized and manageable risk profile.

Category 2: Aesthetic Penile Filler Injections for Girth Enhancement

If a reader’s primary concern is appearance, confidence, girth, or how he looks rather than the mechanics of achieving an erection, he is in a different category entirely.

Aesthetic penile filler injections involve subcutaneous placement of biocompatible filler (primarily hyaluronic acid) beneath the penile skin to increase circumference and improve appearance in both flaccid and erect states. Filler is not injected into erectile tissue. It does not affect vascular function, and it does not treat or worsen erectile dysfunction.

The market context reflects growing demand. Male cosmetic procedures have increased 500 percent over the past 25 years, growing from approximately 3 percent to over 15 percent of cosmetic patients, and the global male aesthetics market reached $5.9 billion in 2024, projected to hit $11.8 billion by 2034. Google Trends data shows searches for “penis filler” rising markedly while traditional “penis enlargement” searches decline, reflecting a shift toward advances in non-surgical penile enhancement solutions. Approximately 12 percent of men perceive their penis as small, and an estimated 3.6 percent ultimately seek enhancement, per Translational Andrology and Urology.

Hyaluronic Acid (HA) Filler: Before and After Outcome Data

The clinical data is robust. A 2025 Journal of Sexual Medicine single-center study of 324 patients reported a mean flaccid girth increase of 2.5 cm, HA longevity of 12 months, and an 89 percent patient-reported satisfaction rate, with no serious adverse events.

A separate 2024 Journal of Sexual Medicine study of 155 men found an average girth increase of 0.633 cm per session; men receiving multiple treatments averaged 1.8 cm total, and those receiving four or more treatments averaged 2.952 cm. A World Journal of Men’s Health multicenter RCT reported mean girth increases of 22.74 mm at 24 weeks, with significant improvements in satisfaction with appearance and sexual life.

Satisfaction rates for injectable girth enhancement consistently range from 75 to 100 percent across published studies, comparable to or exceeding surgical approaches, with significantly lower complication rates. HA is preferred because it is reversible (dissolvable with hyaluronidase), biocompatible, and carries an established safety profile. For the “growers vs. showers” distinction, HA enhances penis girth enhancement in flaccid and erect states most dramatically, which is particularly meaningful for men whose primary concern is confidence in non-erect states.

The HA Filler Before and After Timeline: What to Expect Week by Week

• Day 0 to 3: Visible girth enhancement is apparent immediately. Some swelling temporarily overstates the final result.
• Week 1 to 2: Swelling subsides. A slight perceived reduction from peak is normal, not a sign of filler loss.
• Week 3: A slight dip in perceived volume occurs as initial swelling fully resolves. This is the low point of the visual timeline.
• Week 4 to 6: Collagen stimulation begins. Firmness and definition improve as tissue integrates with the filler.
• Week 6 to 8: Final settled results are visible. This is the true “after” baseline for photography and measurement.
• Months 3 to 12: HA longevity of approximately 12 months, with touch-up sessions available to maintain or build results.

Results look and feel natural in both flaccid and erect states, a key differentiator from surgery. Sexual activity can typically resume within 7 to 10 days.

Filler Material Comparison: Why HA Is the Clinical Standard

The World Journal of Men’s Health RCT found both HA and PLA achieved significant girth augmentation (16.95 mm and 13.49 mm respectively at 18 months), but PLA carries higher complication risk. A 2025 NIH case series documented foreign body granuloma formation after PLA penile filler injection, a serious complication requiring surgical management.

HA offers a safety net: if complications arise or the patient is unsatisfied, it can be dissolved with hyaluronidase. PMMA and silicone should be avoided entirely for penile enhancement, given their association with granuloma, migration, disfigurement, and irreversible complications. The Stoller Medical Group / Penis Enlargement New York City uses Belefil, a hyaluronic acid-based medical-grade penis filler material, consistent with the evidence base. Material selection is one of the most important safety decisions in this field.

The Filler Girth Enhancement Risk Profile: Honest Assessment

Known complication rates for HA penile filler include asymmetry (about 6 percent), migration (about 7.7 percent), lumps (about 4.6 percent), and infection (about 1.5 percent), all manageable with proper technique. By contrast, surgical complication rates run near 53 percent, far higher than injectable approaches, according to Translational Andrology and Urology.

The 2024 JSM study noted 12.3 percent of patients required cosmetic correction, which staged treatments help reduce. Serious complications are primarily associated with non-HA fillers or inexperienced injectors. Provider experience is the single most important risk mitigation factor. The Stoller Medical Group has performed over 15,000 procedures, and hospital-grade sterility protocols are non-negotiable standards worth confirming with any provider.

Side-by-Side Comparison: ED Injections vs. Girth Enhancement Filler

The critical overlap point: neither category delivers what the other is designed for. Both produce meaningful psychological “before and after” outcomes. ED injections restore functional confidence, while girth enhancement restores aesthetic confidence. Men with both concerns may benefit from a staged combination plan, best discussed during a qualified consultation.

How to Identify Which Injectable Category Matches Your Goal

This is a decision framework, not a diagnosis.

• “I want to reliably achieve and maintain a firm erection.” Category 1 (Trimix, BoNT-A, or PRP). Refer to a urologist or men’s health specialist.
• “I want to look and feel larger, more confident, and more proportionate.” Category 2 (HA filler girth enhancement). Consult a qualified aesthetic provider experienced in penile filler.
• “I have mild ED that feels mostly psychological, tied to anxiety about my size.” Category 2 may address the root cause. Psychogenic ED driven by body image can be meaningfully improved through girth enhancement.
• “I have both.” A combination approach, starting with a comprehensive consultation, is worth exploring.

This framework is a tool to arrive at a consultation with clarity, not a substitute for one. The documented shift from “penis enlargement” to “penis filler” searches confirms that men increasingly recognize evidence-based injectable solutions exist.

Why ED Injections Were Never Designed to Deliver Aesthetic Results

Intracavernosal vasoactive injections were developed and FDA-approved exclusively to treat erectile dysfunction. They have no mechanism for increasing girth, length, or improving flaccid appearance. Their “before and after” is measured in rigidity, IIEF scores, and the ability to achieve intercourse, never in centimeters.

A man primarily concerned with how he looks or how he appears to a partner will not find satisfaction in ED injection therapy, because those outcomes fall outside its scope. This is not a criticism of ED injections, which are clinically validated and genuinely life-changing for men with true erectile dysfunction; it is a clarification of scope. A confidence deficit rooted in appearance requires an aesthetic solution, and filler phalloplasty is precisely what ED injections were never designed to deliver.

Filler Phalloplasty at Penis Enlargement New York City: What the Procedure Involves

The Stoller Medical Group / Penis Enlargement New York City is a specialized provider with over 15,000 procedures performed, the clinical experience base that matters most for safety and outcomes.

The procedure is non-surgical and outpatient, completed in under one hour with no cutting and no general anesthesia. Belefil HA-based medical-grade dermal filler is placed beneath the penile skin. Results include immediate visible enhancement, 80 to 90 percent permanent improvement in girth and volume, longevity of 18 to 24 months, and a natural look and feel in both flaccid and erect states with normal sensation preserved.

Recovery is efficient: patients are back on their feet within 10 days (compared to 40-plus days with other permanent fillers), and sexual activity resumes within 7 to 10 days. A staged treatment approach, using multiple sessions rather than one dramatic procedure, reduces risk, improves symmetry, and allows incremental refinement. Results reach an increase of up to 1 to 1.5 inches in girth, consistent with published literature showing mean increases of 1.8 to 2.5 cm across sessions. Five locations across New York (Manhattan, Long Island, Albany), Pennsylvania, and Minnesota offer broad accessibility, and free consultations are available.

Understanding the Investment: Pricing and Treatment Planning

This is a medical-aesthetic procedure performed by experienced specialists, not a commodity service. Pricing starts at $7,500 and increases depending on the patient’s desired results and the number of syringes required. Pricing is structured by syringe: most men begin with a minimum of 10 syringes, and the average first procedure involves approximately 15 syringes.

The staged approach spreads the investment across sessions, allowing patients to assess results and refine goals before committing to additional treatment. The outcome data supports the value: 89 percent patient satisfaction, mean girth increases of 1.8 to 2.5 cm, and 80 to 90 percent permanent improvement represent measurable returns. The free consultation is the appropriate venue to discuss individual anatomy, goals, and a personalized plan. For high-achieving professionals, the confidence and self-image benefits of a successful outcome carry significant personal and professional value.

The Psychological Before and After: Confidence, Performance Anxiety, and Self-Image

Most clinical content ignores the emotional dimension, yet both categories produce a psychological “before and after” that is often more meaningful than the measurements.

For ED injection patients, restored erectile function dramatically reduces performance anxiety and rebuilds a sense of identity that IIEF scores cannot fully capture. For girth enhancement patients, improvements in body image, locker-room confidence, and male sexual confidence are consistently reported, even among men whose partners expressed no prior dissatisfaction.

The confidence-performance connection matters most for men with psychogenic ED driven by body image, where girth enhancement can break the anxiety cycle that perpetuates erectile difficulty, addressing the root cause rather than the symptom. Roughly 12 percent of men perceive themselves as small, and that perception, regardless of objective measurement, drives real distress and avoidance behavior. The high-achieving professional who has never thought a solution existed often carries this concern in silence. Finding a credible, evidence-based option is itself a significant transformation. With male cosmetic procedures up 500 percent over the past 25 years, seeking enhancement is a rational and increasingly common choice.

Conclusion: Two Procedures, One Clear Decision

“Before and after ED injections” describes two fundamentally different clinical categories: intracavernosal vasoactive injections for erectile function, and subcutaneous HA filler injections for aesthetic girth enhancement. ED injections restore function but do not change size. HA filler enhances girth and appearance but does not treat erectile dysfunction. Both are evidence-based and capable of meaningful outcomes when matched to the right goal.

For the reader whose primary concern is confidence, appearance, and size, filler phalloplasty is the solution ED injections were never designed to deliver. Men with both functional and aesthetic concerns have combination options worth exploring. The decision is straightforward once the categories are clear. The next step is a conversation with a qualified specialist. The Stoller Medical Group brings 15,000-plus procedures, five locations, free consultations, and a safety-first philosophy built on staged treatments and HA-based fillers: the clinical foundation for a confident decision.

Ready to See Your Before and After? Schedule a Free Consultation

The consultation is free, carries no commitment, and is available across five convenient locations. Every conversation is confidential; discretion is prioritized at every stage.

The outcome data speaks clearly: 89 percent patient satisfaction, mean girth increases of 1.8 to 2.5 cm, 80 to 90 percent permanent improvement, and a 10-day recovery, all beginning with a single conversation. For the professional who has never thought a solution existed, the solution is evidence-based and accessible. The first step is simply asking the question.

Locations:

• Manhattan: 515 Madison Avenue, Suite 1205
• Long Island: Jericho
• Albany: Latham
• Pennsylvania: Chadds Ford
• Minnesota: Eagan

Booking a consultation is an investment in self, consistent with the standards a high-achieving professional already applies to every other domain of his life.